Mechanisms of chronic rejection.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Current Opinion in Immunology

• Publication date

  2000-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0952-7915(00)00132-1PMID 11007353
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role?

  1999cited by this paper
• Rethinking chronic allograft nephropathy: the concept of accelerated senescence.

  1999cited by this paper
• Non‐heartbeating kidney donors

  1999cited by this paper
• Ischemic preconditioning improves postischemic acute renal failure.

  1999cited by this paper
• Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo.

  1998cited by this paper
• Effects of explosive brain death on cytokine activation of peripheral organs in the rat.

  1998cited by this paper
• High kidney graft survival rates using non-heart-beating trauma donors.

  1998cited by this paper
• Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts.

  1998cited by this paper
• Interleukin-2-Receptor Blockade With Daclizumab to Prevent Acute Rejection in Renal Transplantation

  1998cited by this paper
• Developments in the clinical science of transplantation during the 20th century.

  1998cited by this paper
• The role of T-cell costimulatory activation pathways in transplant rejection.

  1998cited by this paper
• Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.

  1998cited by this paper
• Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection.

  1998cited by this paper
• Central role for CD40/CD40 ligand (CD154) interactions in transplant rejection.

  1998cited by this paper
• Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.

  1998cited by this paper
• Role of reactive oxygen intermediates in interleukin 10 release after cold liver ischemia and reperfusion in mice.

  1997cited by this paper
• T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen.

  1997cited by this paper
• Renal function in the elderly: impact of hypertension and cardiac function.

  1997cited by this paper
• Current and future immunosuppressive therapies: impact on chronic allograft dysfunction.

  1997cited by this paper
• Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4.

  1997cited by this paper
• The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes.

  1997cited by this paper
• CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver.

  1997cited by this paper
• Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction.

  1997cited by this paper
• The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand.

  1997cited by this paper
• Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.

  1997cited by this paper
• CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury.

  1997cited by this paper
• The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury.

  1997cited by this paper
• Prevention of late renal changes after initial ischemia/reperfusion injury by blocking early selectin binding.

  1997cited by this paper
• Leukocytes, cell adhesion molecules and ischemic acute renal failure.

  1997cited by this paper
• Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody.

  1997cited by this paper
• United Network for Organ Sharing Donor Data Update, 1988-1995.

  1997cited by this paper
• Early risk factors contributing to the evolution of long-term allograft dysfunction

  1997cited by this paper
• Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.

  1996cited by this paper
• Lack of effect of recombinant human superoxide dismutase on cold ischemia-induced arteriosclerosis in syngeneic rat aortic transplants.

  1996cited by this paper
• Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.

  1996cited by this paper
• Aging and the kidney.

  1996cited by this paper
• The Impact of Ischemia/Reperfusion Injury on Specific and Non-Specific, Early and Late Chronic Events After Organ Transplantation

  1996cited by this paper
• CTLA-4 ligation blocks CD28-dependent T cell activation [published erratum appears in J Exp Med 1996 Jul 1;184(1):301]

  1996cited by this paper
• B7-2 (CD86) is essential for the development of IL-4-producing T cells.

  1996cited by this paper
• The in vivo mechanism of action of CTLA4Ig.

  1996cited by this paper
• CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response.

  1996cited by this paper
• Ischemia, injury, and renal allograft rejection.

  1996cited by this paper
• Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

  1996cited by this paper
• Both alloantigen-dependent and -independent factors influence chronic allograft rejection.

  1995cited by this paper
• CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2

  1995cited by this paper
• Nephron supply is a major determinant of long-term renal allograft outcome in rats.

  1994cited by this paper
• Activation of tyrosine kinase signal pathways by radiation and oxidative stress.

  1994cited by this paper
• Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function

  1994cited by this paper
• Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.

  1993cited by this paper
• Nephron underdosing: a programmed cause of chronic renal allograft failure.

  1993cited by this paper
• Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

  1993cited by this paper
• Identification of an alternative CTLA-4 ligand costimulatory for T cell activation.

  1993cited by this paper
• Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.

  1992cited by this paper
• Chronic rejection of rat renal allografts. II. The impact of prolonged ischemia time on transplant histology.

  1992cited by this paper

• Physiological Assessment of Coronary Stenoses and the Microcirculation

  2017influential citation
• The Coronary Circulation in Cardiomyopathies and Cardiac Allografts

  2017cites this paper
• Quantitative arterial spin labelling perfusion measurements in rat models of renal transplantation and acute kidney injury at 3T.

  2017cites this paper
• FunctionBronchiolitis: Regulation and CXCR3 and Its Ligands in a Murine Model

  2017cites this paper
• Feasibility of Direct Reprogramming of Myofibroblasts to Lung Epithelial Cells Utilizing PiggyBac Transposon System

  2016cites this paper
• The Potential Role of IL-33 in Renal Transplant Recipients with Chronic Allograft Dysfunction.

  2016cites this paper
• Diagnosis and prevention of chronic kidney allograft loss

  2015cites this paper
• Facial transplantation: historical developments and future directions

  2015cites this paper
• Development of Arterial Spin Labeling Techniques forQuantitative Perfusion Measurements at 3 Tesla

  2014cites this paper
• Biomolekylære markører hos de novo nyretransplanterte pasienter – Endringer i metabolsk aktivitet, puriner og IMPDH-kapasitet i ex vivo-aktiverte lymfocytter.

  2014cites this paper
• Chronic renal allograft dysfunction: risk factors, immunology and prevention.

  2013cites this paper
• The Transplanted Heart

  2013cites this paper
• Immune Protection for Transplanted Pancreatic Islets by Nano-encapsulation Strategies: A Chemist's Insight

  2012cites this paper
• Genetic or Pharmaceutical Blockade of Phosphoinositide 3-Kinase P110δ Prevents Chronic Rejection of Heart Allografts

  2012cites this paper
• Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.

  2012cites this paper
• Donor antigen-specific regulatory T-cell function affects outcome in kidney transplant recipients.

  2011cites this paper
• The Immune Response to Transplanted Organs

  2011cites this paper
• Connective Tissue Growth Factor Promotes Fibrosis Downstream of TGFβ and IL‐6 in Chronic Cardiac Allograft Rejection

  2010cites this paper
• TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection.

  2010cites this paper
• with Chronic Rejection Allograft Acceptance and Fibrosis Associated Signaling and IL-17 in b Role of T Cell TGF

  2009cites this paper
• with Chronic Rejection Allograft Acceptance and Fibrosis Associated Signaling and IL-17 in b Role of T Cell TGF

  2009cites this paper
• with Chronic Rejection Allograft Acceptance and Fibrosis Associated Signaling and IL-17 in b Role of T Cell TGF

  2009cites this paper
• Role of T Cell TGFβ Signaling and IL-17 in Allograft Acceptance and Fibrosis Associated with Chronic Rejection1

  2009cites this paper
• Cytochrome p450 2C Enzymes Contribute to Peritransplant Ischemic Injury and Cardiac Allograft Vasculopathy

  2008cites this paper
• Analysis of Acute and Chronic Rejection in Multiple Organ Allografts From Retransplantation and Autopsy Cases of Multivisceral Transplantation

  2008cites this paper
• Mechanisms of chronic rejection in cardiothoracic transplantation.

  2008cites this paper
• Graft Chemokines and Transplant Vasculopathy

  2008cites this paper
• Contemporaneous chronic rejection of multiple allografts with principal pancreatic involvement in modified multivisceral transplantation

  2007cites this paper
• Risk Assessment of Immunosuppressive Therapy in Facial Transplantation

  2007cites this paper
• A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow‐up

  2007cites this paper
• Research and events leading to facial transplantation.

  2007cites this paper
• Angiogenesis in human parathyroid disease and chronic allograft nephropathy

  2007cites this paper
• Regulatory CD 8 CD 103 Is a Marker for Alloantigen-Induced

  2006cites this paper
• CD103 Is a Marker for Alloantigen-Induced Regulatory CD8+ T Cells

  2006cites this paper
• CXCR3 and Its Ligands in a Murine Model of Obliterative Bronchiolitis: Regulation and Function1

  2006cites this paper
• Immunmonitoring chronischer Abstoßung nach klinischer Nierentransplantation

  2006cites this paper
• Transforming Growth Factor Beta‐Induced Connective Tissue Growth Factor and Chronic Allograft Rejection †

  2006cites this paper
• Functionof Obliterative Bronchiolitis: Regulation and CXCR3 and Its Ligands in a Murine Model

  2006cites this paper
• New technologies for organ replacement and augmentation.

  2005cites this paper
• Pathogenic T‐Cell Recruitment into the Airway in Human Disease

  2005cites this paper
• Excretion of urinary proteins as predictors of early posttransplantation complications and late renal allograft failure

  2005cites this paper
• BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation

  2005cites this paper
• A Randomized Trial of Three Renal Transplant Induction Antibodies: Early Comparison of Tacrolimus, Mycophenolate Mofetil, and Steroid Dosing, and Newer Immune-Monitoring1

  2005cites this paper
• Contribution of CD4+ and CD8+ T cells and interferon-gamma to the progress of chronic rejection of kidney allografts: the Th1 response mediates both acute and chronic rejection.

  2005cites this paper
• 13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy.

  2005cites this paper
• BLT 1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation

  2005cites this paper
• Progression of Alloresponse and Tissue‐Specific Immunity during Graft Coronary Artery Disease

  2005cites this paper
• A Novel Small-Molecule Compound Targeting CCR5 and CXCR3 Prevents Acute and Chronic Allograft Rejection

  2005cites this paper
• KRP-203, a Novel Synthetic Immunosuppressant, Prolongs Graft Survival and Attenuates Chronic Rejection in Rat Skin and Heart Allografts

  2005cites this paper
• Chronic allograft nephropathy: The major problem in long-term survival: Review of etiology and interpretation

  2005cites this paper
• Is thoracic organ transplantation ready for tolerance

  2005cites this paper
• Stromal Cell–Derived Factor-1 and CXCR4 Interaction Is Critical for Development of Transplant Arteriosclerosis

  2004cites this paper
• Strategies for Antigen-Specific Immunomodulation in Experimental Organ Transplantation

  2004cites this paper
• A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. Ii. Survival, function, and protocol compliance at 1 year

  2004cites this paper
• LOW-DOSE ASPIRIN THERAPY IS ASSOCIATED WITH IMPROVED ALLOGRAFT FUNCTION AND PROLONGED ALLOGRAFT SURVIVAL AFTER KIDNEY TRANSPLANTATION

  2004influential citation
• Predictive Genomics of Adverse Events After Cardiac Surgery

  2004cites this paper
• Long time follow up of CD28− CD4+ T cells in living kidney transplant patients

  2004cites this paper
• The FcγRIIa polymorphism in patients with chronic kidney graft rejection

  2004cites this paper
• Plasticity of Bone Marrow–Derived Stem Cells

  2004cites this paper
• Pathogenesis of chronic allograft rejection

  2003cites this paper
• Expression profiling on chronically rejected transplant kidneys1

  2003cites this paper
• γδ T Cells and Interleukin‐6 Levels Could Provide Information Regarding the Progression of Human Renal Allograft

  2003cites this paper
• Modified reperfusion and ischemia-reperfusion injury in human lung transplantation.

  2003cites this paper
• Post‐Transplant Renal Tubulitis: The Recruitment, Differentiation and Persistence of Intra‐Epithelial T Cells

  2003cites this paper
• Regulatory cell-mediated tolerance does not protect against chronic rejection

  2003cites this paper
• Medicament destine a prevenir et/ou a traiter le rejet chronique

  2003cites this paper
• Protection against post-ischemic mitochondrial injury in rat liver by silymarin or TUDC.

  2003cites this paper
• Platelet-derived growth factor in acute and chronic renal allograft rejection

  2003cites this paper
• Long-term limb allograft survival using anti-CD40L antibody in a murine model

  2003cites this paper
• Expression profiling on chronically rejected transplant kidneys.

  2003cites this paper
• Genetic modification of xenografts.

  2003cites this paper
• Chronic Rejection of Small Bowel Grafts: Pediatric and Adult Study of Risk Factors and Morphologic Progression

  2003cites this paper
• Development of intimal hyperplasia in transplant arteriosclerosis

  2003cites this paper
• [Applications of molecular biology to renal transplant].

  2003cites this paper
• Transplant immunobiology: a crucial role for heparan sulfate glycosaminoglycans?

  2003cites this paper
• Effect of conversion from cyclosporine A to mizoribine on transplant arteriosclerosis in rat aortic allograft models

  2003cites this paper
• Rapamycin in cardiovascular medicine

  2003cites this paper
• Kimura disease in a patient with renal allograft failure secondary to chronic rejection

  2003cites this paper
• Migration of mesenchymal stem cells to heart allografts during chronic rejection

  2003cites this paper
• Tubulitis in renal allograft rejection: role of transforming growth factor-&bgr; and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells1

  2003cites this paper
• T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection.

  2002cites this paper
• Interleukin 1 and Chronic Rejection: Possible Genetic Links in Human Heart Allografts

  2002cites this paper
• Modulation of peripheral-type benzodiazepine receptor levels in a reperfusion injury pig kidney-graft model1

  2002cites this paper
• Regulatory functions of alloreactive Th2 clones in human renal transplant recipients.

  2002cites this paper
• The role of mitochondria in ischemia/reperfusion injury

  2002cites this paper
• Polyethylene Glycol Reduces Early and Long-Term Cold Ischemia-Reperfusion and Renal Medulla Injury

  2002cites this paper
• Overcoming cardiac allograft vasculopathy (CAV) by inducing tolerance.

  2002cites this paper
• T-Cell Costimulatory Pathways Relevant to Transplant Rejection and Tolerance

  2002cites this paper
• Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat.

  2002cites this paper
• Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection.

  2002cites this paper
• Determinants of Long-Term Graft and Patient Survival after Transplantation of Kidney and Liver

  2002cites this paper
• Centrilobular necrosis in children after combined liver and small bowel transplantation.

  2002cites this paper
• Detection of cardiac myosin-specific autoimmunity in a model of chronic heart allograft rejection.

  2001cites this paper
• The effect of HMG-CoA reductase inhibitors on chronic allograft rejection

  2001cites this paper
• Studies With T Cell Lines and Clones and their Implications for the Understanding of Mechanisms in Pediatric Graft Rejection and Tolerance

  2001cites this paper
• Clinical impact of delayed graft function for kidney transplantation

  2001cites this paper
• Tailoring tolerance to prevent chronic rejection.

  2001cites this paper
• Renal allograft rejection: The development and function of tubulitis

  2001cites this paper
• Immunosuppressive strategies for prevention of transplant rejection

  2001cites this paper